ACER THERAPEUTICS INC filings

SEC filings by ACER THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2023-03-30TVM Life Science Ventures VI LPAcer Therapeutics Inc.248,7561.1%EDGAR
SC 13G/A2023-02-14Nantahala Capital Management, LLCAcer Therapeutics Inc.1,226,1917.5%EDGAR
SC 13D/A2022-12-02Schelling ChrisAcer Therapeutics Inc.2,858,99516.0%EDGAR
SC 13G/A2022-02-14Nantahala Capital Management, LLCAcer Therapeutics Inc.901,2906.3%EDGAR
SC 13G/A2021-02-12Nantahala Capital Management, LLCAcer Therapeutics Inc.989,7558.1%EDGAR
SC 13G/A2020-08-06HIRSCHMAN ORINAcer Therapeutics Inc.982,4468.5%EDGAR
SC 13D/A2020-08-03Schelling ChrisAcer Therapeutics Inc.1,951,36917.3%EDGAR
SC 13G2020-05-19HIRSCHMAN ORINAcer Therapeutics Inc.552,0405.4%EDGAR
SC 13G/A2020-02-13Vivo Opportunity, LLCAcer Therapeutics Inc.00.0%EDGAR
SC 13G/A2020-02-12Nantahala Capital Management, LLCAcer Therapeutics Inc.990,6559.8%EDGAR
SC 13D/A2019-04-19AVEGO HEALTHCARE CAPITAL, LLCAcer Therapeutics Inc.111,5261.1%EDGAR
SC 13G/A2019-02-14Vivo Opportunity, LLCAcer Therapeutics Inc.579,0515.8%EDGAR
SC 13G2019-02-14Nantahala Capital Management, LLCAcer Therapeutics Inc.903,4559.0%EDGAR
SC 13G2018-09-17Vivo Opportunity, LLCAcer Therapeutics Inc.536,3775.3%EDGAR
SC 13D/A2018-08-24TVM Life Science Ventures VI LPAcer Therapeutics Inc.2,672,30926.6%EDGAR
SC 13D/A2018-08-24TVM Life Science Ventures VI LPAcer Therapeutics Inc.2,672,30926.6%EDGAR
SC 13D2018-02-16TVM Life Science Ventures VI LPAcer Therapeutics Inc.2,397,30932.0%EDGAR
SC 13D2017-09-29Schelling ChrisAcer Therapeutics Inc.1,750,00027.1%EDGAR
SC 13D2017-09-28AVEGO HEALTHCARE CAPITAL, LLCAcer Therapeutics Inc.527,9838.2%EDGAR
SC 13D/A2016-12-08Albert & Margaret Alkek FoundationOpexa Therapeutics, Inc.14,9040.2%EDGAR